Objectives: Unethical drug promotion is a common problem worldwide. In, Nepal, there is limited vigilance on the quality of information supplied by the drug companies to t'/>
Evaluation of drug promotional materials in a hospital setting in Nepal
id="__p1" class="p p-first">Objectives: Unethical drug promotion is a common problem worldwide. In, Nepal, there is limited vigilance on the quality of information supplied by the drug companies to the doctors. The objectives of this study were to analyze the promotional materials provided by the drug companies as per WHO ethical criteria for medicinal drug promotion. id="__p2">Methods: Promotional materials present in the Drug Information Center (DIC) during the period from September to December 2007 were collected. The collected promotional materials of different pharmaceutical companies were compared with WHO’s Ethical Criteria for Medicinal Drug Promotion. id="__p3">Results: The name of active constituent(s) was mentioned in 87.87% (n=29) of promotional items. Therapeutic indication was mentioned in 87.88% (n=29) of promotional material but information on side effects [33.33% (n=11)], drug interactions [9.09% (n=3)] and use in pregnancy and lactation [12.12% (n=4)] were lacking in the majority of promotional materials. id="__p4" class="p p-last">Conclusion: In a country like Nepal with limited drug information resources, the promotional materials provided by the manufacturers can largely influence the prescription behavior of the clinicians. Our findings suggest the need for interventions to improve the content of the promotional materials provided by the drug companies.
展开▼
机译：id =“ __ p1” class =“ p p-first”>目标：不道德的毒品宣传是全球范围内的常见问题。在尼泊尔，对药品公司提供给医生的信息质量的警惕性有限。这项研究的目的是按照世界卫生组织关于药用药物促销的道德标准，分析药品公司提供的促销材料。 id =“ __ p2”>方法：收集了2007年9月至2007年12月期间药物信息中心（DIC）中的宣传材料。将收集到的不同制药公司的促销材料与WHO的《药品促销道德标准》进行了比较。 id =“ __ p3”>结果：促销项目的87.87％（n = 29）中提到了有效成分的名称。促销材料中提到了87.88％（n = 29）的治疗指征，但有关副作用的信息[33.33％（n = 11）]，药物相互作用[9.09％（n = 3）]以及在怀孕和哺乳期使用的信息[12.12％ （n = 4）]缺乏大多数宣传材料。结论：在像尼泊尔这样的药品信息资源有限的国家，制造商提供的促销材料会在很大程度上影响临床医生的处方行为。我们的发现表明，需要采取干预措施来改善药品公司提供的宣传材料的内容。
展开▼
